Everscale vs Injective — how do they compare? Everscale trades at Rp169.86 (market cap Rp334,77M, Rp2,11M 24h volume), while Injective trades at Rp92,485 (market cap Rp9,38T, Rp1,76T 24h volume). The key difference: Injective is far larger — about 28019.2× Everscale's market cap, and Everscale's circulating supply is 2B EVER versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Everscale for 5 Days and Injective for 36 Days on average.
| EVER | INJ | |
|---|---|---|
Market Cap | Rp334,77M | Rp9,38T |
Volume (24h) | Rp2,11M | Rp1,76T |
Circulating Supply | 2B EVER | 100M INJ |
Typical Hold Time | 5 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Everscale (EVER) shows a market cap of Rp334.77M with 2M tokens in circulation, indicating a relatively small-cap cryptocurrency. The token has a short hold time of 5 days, suggesting active trading but limited long-term holding. Recent technical analysis reveals moderate volatility with the current price zone showing consolidation patterns. The network maintains steady on-chain activity with consistent transaction volumes, though no major protocol upgrades have been announced recently.
Overall outlook remains cautious with limited upside potential given the token's small market presence. Key opportunities include potential ecosystem growth and increased adoption, while major risks involve high volatility, low liquidity, and regulatory uncertainties common to emerging crypto assets. Investors should monitor network development progress and exchange liquidity improvements.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Everscale is a secure and fast layer-one blockchain designed to be a decentralized platform for high-performance applications with real-world relevance, such as stablecoins, CBDCs, DEXs, bridges, Gaming platforms, and more.
Read more on EVER →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →